Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 30, 1998
Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
H Kimura, Y Kasahara, K Kurosu, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 1998
Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects
O Kozawa, T Uematsu, H Matsuno, et al.
Mutation Research
|
November 7, 1998
A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity
D L Ludwig, M A MacInnes, Y Takiguchi, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 21, 2001
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension
H Kimura, O Okada, N Tanabe, et al.
Cell Death & Disease
|
November 14, 2014
Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions
S Okamoto, Y Jiang, K Kawamura, et al.
Cancer Gene Therapy
|
January 7, 2012
Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed
Q Li, K Kawamura, M Yamanaka, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure
Y Hayashi, J Katada, T Harada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2021
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary
J Tanizaki, K Yonemori, K Akiyoshi, et al.
ESMO Open
|
March 23, 2024
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM
S Watanabe, H Yoshioka, H Sakai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
K Kubota, H Sakai, N Katakami, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 30, 1998
Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
H Kimura, Y Kasahara, K Kurosu, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 1998
Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects
O Kozawa, T Uematsu, H Matsuno, et al.
Mutation Research
|
November 7, 1998
A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity
D L Ludwig, M A MacInnes, Y Takiguchi, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 21, 2001
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension
H Kimura, O Okada, N Tanabe, et al.
Cell Death & Disease
|
November 14, 2014
Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions
S Okamoto, Y Jiang, K Kawamura, et al.
Cancer Gene Therapy
|
January 7, 2012
Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed
Q Li, K Kawamura, M Yamanaka, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure
Y Hayashi, J Katada, T Harada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2021
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary
J Tanizaki, K Yonemori, K Akiyoshi, et al.
ESMO Open
|
March 23, 2024
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM
S Watanabe, H Yoshioka, H Sakai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
K Kubota, H Sakai, N Katakami, et al.
Page
of 16